Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical - Los Angeles, United States - FDA Site Report

FEI Number: 3013341563

Overview Statistics

2
Total Inspections
2
Total 483s Issued
1
Warning Letters Issued
100.0%
483 Issue Rate

Site Details

Last Inspected: 2019-12-20

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical - Recent Inspections

DateInvestigatorsCategoryDays483
2019-12-20
Erika V Butler
Human Drugs19 days
2017-03-23
Marcellinus D Dordunoo
Linda F Murphy
Taichun Qin
Human Drugs11 days
Last Updated: 2025-05-14 06:12:51